SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS Life Sciences is gaining significant attention as bullish investors react to the CEO's recent remarks hinting at "curative outcomes" for its lead AML immunotherapy, GPS, fueling high conviction about its potential and sparking discussions of a substantial short squeeze.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is trending due to renewed short squeeze speculation and anticipation surrounding upcoming earnings, with community discussion highlighting favorable technical chart patterns and the company's robust cash position amid its ongoing business transformation.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

The United States Oil Fund (USO) is trending as escalating Middle East tensions, particularly the Strait of Hormuz closure and production cuts by key oil producers, have sent crude prices soaring. Community discussion is highly polarized, with some anticipating further parabolic gains, while others foresee a sharp pullback as G7 nations consider a significant strategic oil reserve release and potential escort missions to reopen the strait.

AN2 Therapeutics, Inc. operates as a global health biopharmaceutical company. The firm focuses on modern biomedical and drug development to provide transformational medicines for patients suffering from infectious diseases. The company was founded by Eric Easom, George Harrison Talbot, Joseph S. Zakrzewski and Michael R.K. Alley and is headquartered in Menlo Park, CA.

AN2 Therapeutics Inc

ANTX is trending due to a cluster of recent positive developments including a $40 million private placement, new strategic partnerships with GSK and DNDi, and an analyst upgrade, sparking intense community debate between aggressive bulls targeting significant price appreciation and bears pointing to past trial setbacks and potential dilution.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers Health Inc. is trending after resolving its legal dispute with Novo Nordisk and announcing a partnership to offer FDA-approved GLP-1 weight-loss medications on its platform. This development has largely eliminated the previous bear thesis, fueling significant short-squeeze speculation and community discussion about the company's long-term potential as a digital health and wellness platform.

SSgA Active Trust - State Street SPDR S&P 500 ETF Trust

SPY is trending as it staged a notable rebound from an early dip driven by escalating Middle East tensions and oil price spikes, surprising many bears who had anticipated a market collapse amid reports of oil tankers transiting the Strait of Hormuz and discussions of G7 reserve releases.

Volatility Shares Trust - 2x Long VIX Futures ETF

Volatility Shares 2x Long VIX Futures ETF

UVIX is trending as escalating Middle East tensions and surging oil prices fuel expectations for increased market volatility, with the community sharply divided between those buying dips as a market hedge and others anticipating a "VIX crush" or inherent decay in the leveraged ETF.

ProShares Trust - ProShares UltraShort Bloomberg Crude Oil -2x Shares

ProShares UltraShort Bloomberg Crude Oil

ProShares UltraShort Bloomberg Crude Oil ($SCO) is a hot topic as the community actively positions for a significant downturn in crude prices. Many anticipate a reversal from recent highs, believing the surge linked to geopolitical concerns and supply worries may be overextended, with discussions focused on potential reserve releases.

Relmada Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in addressing diseases of the central nervous system. It develops esmethadone, an N-methyl-D-aspartate receptor antagonist for the treatment of CNS diseases, and oral agent for depression and other potential indications. The company was founded by Paolo Manfredi on May 31, 2012 and is headquartered in Coral Gables, FL.

Relmada Therapeutics Inc

Relmada Therapeutics is trending following positive 12-month Phase 2 trial data for its bladder cancer candidate, NDV-01, which reported a durable 76% complete response rate and reinforced plans for Phase 3 trials. The company's recently announced $160 million private placement to fund further development is also a key talking point, with the community actively discussing the drug's potential and the financing's implications for its future trajectory.

Aureus Greenway Holdings, Inc. engages in the ownership and operation of public golf country clubs, namely Kissimmee Bay Country Club and Remington Golf Club. It operates through the following segments: Golf Recreation, Retail Golf Products, and Equipment and Facilities Rental, Membership Dues, Food and Beverage Services, and Ancillary Services and Amenities. The Golf Recreation, Retail Golf Products, and Equipment and Facilities Rental segment is involved in the collection of fees for every round of eighteen holes, provision of driving ranges for practice, sale of golf apparel and equipment, and rental of golf products and cars. The Membership Dues segment refers to the membership fees for customers to access the club's facilities and services for a set period or daily at the point of sale. The Food and Beverage Services segment provides culinary services such as catering. The Ancillary Services and Amenities segment offers leisure activities hosted in an on-premises clubhouse, kitchen, bar, and dining area. The company was founded on December 22, 2023 and is headquartered in Kissimmee, FL.

Aureus Greenway Holdings Inc.

Aureus Greenway Holdings is trending due to its announced merger with drone manufacturer Powerus, backed by Eric and Donald Trump Jr., signaling a significant pivot into the defense-drone sector amid rising military tech demand. Community discussion reflects strong enthusiasm for potential government contracts and short squeeze opportunities, while also acknowledging concerns around the stated merger valuation and recent share dilution.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Jefferies Financial Group Inc. Takes Position in Abivax SA Sponsored ADR $ABVX

Jefferies Financial Group Inc. bought a new stake in Abivax SA Sponsored ADR (NASDAQ:ABVX - Free Report) in the 3rd quarter, according to its most recent 13F filing with the SEC. The firm bought...

Abivax SA Sponsored ADR (NASDAQ:ABVX) Receives Consensus Rating of "Moderate Buy" from Brokerages

Shares of Abivax SA Sponsored ADR (NASDAQ:ABVX - Get Free Report) have earned an average recommendation of "Moderate Buy" from the thirteen research firms that are covering the stock, Marketbeat.com...

Abivax SA Sponsored ADR (NASDAQ:ABVX) Short Interest Down 13.2% in February

Abivax SA Sponsored ADR (NASDAQ:ABVX - Get Free Report) was the target of a large drop in short interest in February. As of February 13th, there was short interest totaling 3,172,758 shares, a drop...

Pharming Group Gears Up to Report Q4 Earnings: What's in the Cards?

PHAR heads into Q4 results, with Ruconest and Joenja sales in focus, pipeline updates looming, and investors eyeing clarity on key regulatory setbacks.

Erste Asset Management GmbH Buys New Position in Abivax SA Sponsored ADR $ABVX

Erste Asset Management GmbH purchased a new position in shares of Abivax SA Sponsored ADR (NASDAQ:ABVX - Free Report) in the 3rd quarter, according to the company in its most recent filing with the...

Envestnet Asset Management Inc. Acquires New Stake in Abivax SA Sponsored ADR $ABVX

Envestnet Asset Management Inc. bought a new stake in shares of Abivax SA Sponsored ADR (NASDAQ:ABVX - Free Report) in the third quarter, according to its most recent 13F filing with the Securities...

Optiver Holding B.V. Makes New Investment in Abivax SA Sponsored ADR $ABVX

Optiver Holding B.V. bought a new stake in Abivax SA Sponsored ADR (NASDAQ:ABVX - Free Report) during the third quarter, according to the company in its most recent Form 13F filing with the...

Abivax's (ABVX) "Buy" Rating Reiterated at BTIG Research

BTIG Research reissued a "buy" rating and issued a $150.00 price objective on shares of Abivax in a research note on Wednesday...

Abivax (NASDAQ:ABVX) Shares Down 5.4% - Here's Why

Abivax (NASDAQ:ABVX) Shares Down 5.4% - Here's Why...

Patient Square Capital LP Purchases Shares of 151,833 Abivax SA Sponsored ADR $ABVX

Patient Square Capital LP purchased a new position in Abivax SA Sponsored ADR (NASDAQ:ABVX - Free Report) in the third quarter, according to the company in its most recent 13F filing with the...

Abivax SA engages in the sale, research, distribution, and development of biopharmaceutical products. It offers commercial and development products of anti-viral compounds and human vaccines. The commercialized products include vaccines for typhoid fever, meningococcus, and leptospirosis. The products under development include vaccines for chronic hepatitis B, ebola, and dengue virus. The company was founded by Philippe Pouletty on December 4, 2003 and is headquartered in Paris, France.

ABVX
Abivax - ADR

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ABVX News

ABVXAbivax - ADR